MyHep
Sofosbuvir 400mg

MyHep 400 mg tablet of Mylan is a generic version of Sovaldi from Gilead. Sofosbuvir 400 mg is a prescription medicine used with other antiviral medicines to treat chronic (lasting a long time) hepatitis C genotype 1, 2, 3, and 4 infection in adults. Compared to previous treatments, sofosbuvir based regimens provide a higher cure rate, fewer side effects, and a two- to four-fold reduced duration of therapy

Sofosbuvir mechanism of action involves inhibiting the enzyme which is necessary for the virus multiplication. A complete cure may even be possible using MyHep (Sofosbuvir). Chronic hepatitis C is a serious infection of the liver which occurs following an infection with the hepatitis C virus. Upon reaching the cells of the liver, the virus begins to multiply, which it achieves by means of copying its DNA and RNA. MyHep  (Sofosbuvir) of Myhep is known as a nucleotide polymerase inhibitor, and it works directly on the virus itself.


MyHepMyHep  
AVAILABLE AS:
SOFOSBUVIR 400MG
PACK : 28 TABLETS BOTTLE
MANUFACTURE BY:
Mylan India.

 

  • Dosage and Administration
    The dosage of Myhep (sofosbuvir) of Mylan schedule must be individualized by the physician in charge of treatment, and will vary according to the viral genotype that is being treated.
    The recommended daily dose of Sofosbuvir is 400mg tablet to be taken once daily with or without food. Sofosbuvir should be used in combination with Ribavirin or in combination with Pegylated Interferon and Ribavirin for the treatment of CHC (Chronic Hepatitis C) in adults.

This medicine is to be taken strictly under Medical  Supervision  of Hepatologist/Gastroenterologist/HCV  only